Nolato AB (publ) (STO:NOLA.B)
Sweden
· Delayed Price · Currency is SEK 49.90
-1.15 (-2.25%)
At close: Mar 9, 2026
Nolato AB Revenue
In the year 2025, Nolato AB had annual revenue of 9.46B SEK, down -2.09%. Nolato AB had revenue of 2.27B in the quarter ending December 31, 2025, a decrease of -4.62%.
Revenue
9.46B
Revenue Growth
-2.09%
P/S Ratio
1.42
Revenue / Employee
1.72M
Employees
5,491
Market Cap
13.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.46B | -202.00M | -2.09% |
| Dec 31, 2024 | 9.66B | 118.00M | 1.24% |
| Dec 31, 2023 | 9.55B | -1.23B | -11.40% |
| Dec 31, 2022 | 10.77B | -836.00M | -7.20% |
| Dec 31, 2021 | 11.61B | 2.25B | 24.05% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitrolife AB | 3.44B |
| Elekta AB | 17.11B |
| MedCap AB | 2.11B |
| Xvivo Perfusion AB | 812.17M |
| Sectra AB | 3.52B |
| CellaVision AB | 748.45M |
| Getinge AB | 34.97B |
| BICO Group AB | 1.50B |
Nolato AB News
- 25 days ago - Nolato AB (NLTBF) Q4 2025 Earnings Call Highlights: Resilient Growth Amid Currency Challenges - GuruFocus
- 25 days ago - Q4 2025 Nolato AB Earnings Call Transcript - GuruFocus